CALA - カリセラ・バイオサイエンシズ (Calithera Biosciences Inc.)

CALAのニュース

   Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021  2021/07/29 11:00:00 Intrado Digital Media
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Companys second quarter 2021 financial results will be released on Thursday, August 5, 2021. Company management will host a conference call on Thursday, August 5, 2021 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
   Waldenstrom Macroglobulinemia Therapeutics Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: BeiGene(Beijing) Co.,Ltd, Calithera Biosciences, Inc., Celgene Co  2021/07/25 23:28:18 Jumbo News
The documented report on Global Waldenstrom Macroglobulinemia Therapeutics Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or []
   Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/20 22:29:42 Stock Equity
Exxon Mobil Corporation (NYSE:XOM) with the stream of 1.19% also noticed, India Calithera Biosciences, Inc. (NASDAQ:CALA) encountered a rapid change of 2.78% in the last hour of Tuesdays trading session. The post Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/14 23:00:55 Stock Equity
Nikola Corporation (NKLA) with the stream of -1.40% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -2.59% in the last hour of Wednesdays trading session. Nikola The post Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/12 22:55:48 Stock Equity
Freeport-McMoRan Inc. (FCX) with the stream of 0.08% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -3.45% in the last hour of Mondays trading session. Freeport-McMoRan The post Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/20 22:29:42 Stock Equity
Exxon Mobil Corporation (NYSE:XOM) with the stream of 1.19% also noticed, India Calithera Biosciences, Inc. (NASDAQ:CALA) encountered a rapid change of 2.78% in the last hour of Tuesdays trading session. The post Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/14 23:00:55 Stock Equity
Nikola Corporation (NKLA) with the stream of -1.40% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -2.59% in the last hour of Wednesdays trading session. Nikola The post Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA)  2021/07/12 22:55:48 Stock Equity
Freeport-McMoRan Inc. (FCX) with the stream of 0.08% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -3.45% in the last hour of Mondays trading session. Freeport-McMoRan The post Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
   The Daily Biotech Pulse: Lilly, Morphic''s Positive Data At ECCO, Humanigen''s COVID Treatment Gets Expedited Review In UK, TransCode IPO  2021/07/09 11:36:16 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO ) ( moved on positive analyst action) Ambrx Biopharma Inc. (NYSE: AMAM ) AtriCure, Inc. (NASDAQ: ATRC ) Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Edwards Lifesciences Corporation (NYSE: EW ) Novo Nordisk A/S (NYSE: NVO ) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 8) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) ADMA Biologics, Inc. (NASDAQ: ADMA ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) (announced positive Phase 2 data for non-alcoholic steatohepatitis drug) Allogene Therapeutics, Inc.
   Calithera to Present at the Jefferies 2021 Virtual Healthcare Conference  2021/05/27 00:00:00 BioSpace
Calithera Biosciences, Inc., a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, announced that Susan Molineaux, Ph.D., the companys founder, president and chief executive officer, will present at the Jefferies 2021 Virtual Healthcare Conference on Friday, June 4, 2021 at 9:00 am ET.
   Calithera to Present at the Jefferies 2021 Virtual Healthcare Conference  2021/05/27 00:00:00 BioSpace
Calithera Biosciences, Inc., a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, announced that Susan Molineaux, Ph.D., the companys founder, president and chief executive officer, will present at the Jefferies 2021 Virtual Healthcare Conference on Friday, June 4, 2021 at 9:00 am ET.
   Calithera, Antengene Announce Licensing Agreement For CB-708 In Cancer Settings  2021/05/17 14:08:02 Benzinga
Calithera Biosciences Inc (NASDAQ: CALA ) and Antengene Corporation Ltd have announced an exclusive, worldwide license agreement for the development and commercialization of CB-708. CB-708 is a highly potent, Full story available on Benzinga.com
   Calithera Biosciences and Antengene ink worldwide exclusive license agreement  2021/05/17 12:29:55 Seeking Alpha
   Calithera, Antengene Ink Exclusive Global License Deal For Development Of CB-708 - Quick Facts  2021/05/17 12:22:34 Business Insider Markets
(RTTNews) - Biotechnology company Calithera Biosciences, Inc. (CALA) and Hong Kong-based Antengene Corp. announced an exclusive, worldwide license agreement for the development and commercialization of CB-708, Calithera''s small molecule inhibitor of CD73. CB-708 is a highly potent, selective, orally-bioavailable small molecule inhibitor of CD73.
   Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708  2021/05/17 00:00:00 BioSpace
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, and Antengene Corporation, Ltd. (SEHK: 6996.HK), a leading clinical-stage R&D driven biopharmaceutical company focused on innovative medicines for oncology and other life-threatening diseases

calendar